Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort.
Heba M BintalibDavid M LoweGaia MancusoGeorgia GkrepiSuranjith L SeneviratneSiobhan O BurnsJohn R HurstPublished in: ERJ open research (2022)
Corticosteroids improve gas transfer in GLILD, but patients often relapse. The use of MMF was associated with long-term effectiveness in GLILD and permits weaning of corticosteroids. A delay in initiating and continuing maintenance treatment could lead to disease progression.
Keyphrases
- interstitial lung disease
- lung function
- systemic sclerosis
- end stage renal disease
- chronic kidney disease
- rheumatoid arthritis
- ejection fraction
- randomized controlled trial
- chronic obstructive pulmonary disease
- newly diagnosed
- systematic review
- idiopathic pulmonary fibrosis
- prognostic factors
- peritoneal dialysis
- high glucose
- diabetic rats
- cross sectional
- systemic lupus erythematosus
- drug induced
- room temperature
- endothelial cells
- cell therapy